2 june 2022 |
|
18:30 |
FuelPositive Corporation ("FuelPositive" or the "Company") is pleased to announce that it has filed a U.S. Non-Provisional Patent Application for the Company's "Modular Transportable Clean Hydrogen-Ammonia Maker" with the United States Patent and... |
17:30 |
Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today released highlights from a key opinion leader (KOL) and... |
14:40 |
An op-ed, Why is plain packaging for e-cigarettes no longer required in B.C.?, published by The Province, questions British Columbia's decision to amend the plain packaging requirement for vape products. The authors imply that this decision was the... |
08:30 |
InterCure Ltd. ("InterCure" or the "Company") announced today the grand opening of its flagship Cookies pharmacy in Be'er Sheva, the largest city in Israel's southern region, known as the capital of the Negev. The pharmacy is located in the... |
07:00 |
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that treatment with... |
1 june 2022 |
|
17:00 |
Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... |
11:00 |
The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that brings together the type 1 diabetes (T1D) community to unite and raise funds for T1D research with the goal of raising $2.8M this year. During the month of... |
09:00 |
The ALS Society of Canada (ALS Canada) joins the global ALS community in recognizing June as ALS Awareness Month. More than 3,000 Canadians live with amyotrophic lateral sclerosis (ALS), a neuromuscular disease that paralyzes people because the brain... |
07:00 |
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous... |
05:00 |
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Roy W. Beck will moderate a session: The Insulin-Only Bionic Pancreas Pivotal... |
04:00 |
Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification of breast cancers, Stratipath Breast, is now CE-IVD marked. This paves the way for clinical... |
31 may 2022 |
|
17:55 |
Dundee Corporation (the "Corporation" or "Dundee") today announces that TauRx Pharmaceuticals Ltd. ("TauRx"), a leader in tau-based research in Alzheimer's, unveiled initial data from the randomised portion of their widely followed Phase 3 clinical... |
16:15 |
Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the voting results from the Company's annual... |
13:20 |
The AdvantAge Ontario Board of Directors is pleased to announce the election of Sue Graham-Nutter as Chair. Sue is the CEO of the Rekai Centres, a non-profit, charitable corporation that has two long-term care (LTC) homes located in downtown... |
09:00 |
Seniors have spoken: Health plans need to support more than medical care, according to a new national survey from Virgin Pulse, the leading global digital-first health and wellbeing company. The survey of Americans ages 65+ provides insights about... |
08:40 |
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that an abstract highlighting real-world data, which shows the impact of translingual neurostimulation as a... |
07:40 |
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced the publication on May 30, 2022 of the results from the pivotal GEMINI... |
07:00 |
ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), the Plant-Based baby, toddler, and children nutrition company, is pleased to announce that it has concluded a second successful preclinical study on its Plant-Based infant... |
07:00 |
Revive Therapeutics Ltd. ("Revive"... |
05:05 |
Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications. Conagen's dihydro resveratrol is made by bioconversion from p-coumaric acid... |
30 may 2022 |
|
10:25 |
A global day to celebrate togetherness, solidarity, and a vision for a multiple sclerosis (MS) free world, World Multiple Sclerosis (MS) Day on May 30 brings the entire MS Community together to build connections and raise awareness about the impact... |
08:30 |
Across Canada, post-secondary students are preparing to make a difference in their areas of study and communities. The RTOERO scholarship program is helping 20 of them to get there. This year, RTOERO has awarded scholarships valued at $3,000 each... |
06:30 |
The O'Cannabiz International Conference, Awards and Expo, the leading industry event to showcase and promote cannabis brands, is now open for registration. After an 18-month hiatus, the annual event will run between June 1-3 at the International... |
28 may 2022 |
|
08:00 |
After two years, Le Bal Rouge was back with a vengeance. This year's fiery edition raised funds in support of MI4, the McGill Interdisciplinary Initiative in Infection and Immunity. The glamourous event, attended by 520 guests and held on Friday, May... |
27 may 2022 |
|
18:40 |
LifeLabs recently hosted the grand opening of its newest Patient Service Centre at 8315 Financial Drive in Southwest Brampton. The Honourable Prabmeet Singh Sarkaria, Progressive Conservative Candidate for Brampton South, joined LifeLabs to celebrate... |
17:00 |
Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... |
09:00 |
Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into a... |
08:05 |
Today, MedMira Inc. (MedMira) provides an update on its regulatory progress in Europe and any market accepting the CE mark. MedMira has received the CE mark for three products in 2022 and has four additional applications currently pending with the... |
26 may 2022 |
|
08:30 |
NetworkNewsAudio ? Lexaria Bioscience Corp. announces the availability of a broadcast titled, "Nicotine Surges as Smoking Sags." To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please... |
06:30 |
When Yippie activists held their annual Smoke-Ins in Washington, D.C. in the ?70s, Steve DeAngelo was a key organizer. In 2019, when pot was legal almost everywhere, but people still languished in jail for it, DeAngelo took up their cause with his... |
25 may 2022 |
|
13:15 |
Biosenta Inc. (the "Company" or "Biosenta") is developing environmentally friendly biocidal particles that are successfully tested against infectious bacteria growing on common surfaces. The particles are developed in collaboration with Dr. Maen... |
09:25 |
The Breast Cancer Society of Canada (BCSC) today announced the recipients of their first-ever Breast Cancer Research request for proposals. Researchers from across Canada were invited to submit projects last December for funding consideration in 2022... |
08:45 |
In the midst of Skin Cancer Awareness Month, Colorescience®, a leading dermatologist-recommended specialty skincare and cosmetics company announces published results in The Journal of Clinical and Aesthetic Dermatology, An Open-Label Study Assessing... |
08:30 |
Aptose Biosciences Inc. , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that it will host a key opinion leader (KOL) webinar on HM43239 and... |
08:00 |
Blender Bites Ltd. (the "Company", "Blender Bites" or "Blender"), , an award winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to... |
07:00 |
PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a company focused on the development and commercialization of specialty ketamine products, and CC... |
06:30 |
Being the first Black woman to own a cannabis dispensary in the U.S. is not exactly an honour as far as Wanda James is concerned. To her, it merely underscores that the industry is 98% white-owned. "Things like ?first' and ?only' just motivate me... |
04:00 |
May 25, 2022 Over 17 million people in underserved communities provided with access to quality healthcare in 2021 New social impact investment vehicle established to help nurture early-stage social enterprises Disaster relief in times of crisis... |
24 may 2022 |
|
23:25 |
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the... |
19:25 |
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai recently announced the creation of the Center for Engineering and Precision Medicine (CEPM), one of the first centers in the nation to bridge engineering and engineering... |
13:55 |
In an announcement issued earlier today under the same headline by SOLVE FSHD, please be advised that in the second paragraph, "Children's National Medical Center" should be "Children's National Hospital." Complete corrected text follows: SOLVE... |
12:00 |
Datavant, the leader in helping organizations securely connect health data today announced that the National COVID Cohort Collaborative Privacy-Preserving Record Linkage (N3C PPRL), powered by Datavant technology and Regenstrief Institute's Linkage... |
08:00 |
SOLVE FSHD, the venture-philanthropy organization founded by entrepreneur Chip Wilson, announces its financial support to the FSHD Canada Foundation's strategic investment of US$1.2M in biomarker grant funding to facilitate biomarker research in... |
07:30 |
Knight Therapeutics Inc. , a pan-American (ex-USA) specialty pharmaceutical company, today announced that it has entered into exclusive license and supply agreements with Rigel Pharmaceuticals granting Knight the rights to commercialize fostamatinib,... |
07:30 |
Adult-use cannabis market share increased three positions to 13th in April 2022 vs 16th in December 2021(1)53% increase in adult-use market share to 2.5% in April 2022 vs December 2021(2), representing the 5th highest growth rate among the top 40... |
23 may 2022 |
|
16:00 |
Blender Bites Ltd. (the "Company", "Blender Bites" or "Blender"), , an award winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to... |
14:30 |
URAC, the nation's largest independent health care accreditation organization and the undisputed recognized leader in pharmacy accreditation, announced today that is has entered into an agreement with CARE Pharmacies Cooperative Inc., a growing... |
10:20 |
Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a late-breaking presentation of results from the CCM-HFpEF Piloty Study, which is the largest clinical trial to date... |
09:15 |
The Davos Alzheimer's Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer's disease, today announced the recipients of a grant program aiming for early detection of cognitive symptoms. The early... |
08:30 |
Nymox Pharmaceutical Corporation reports today that it has received a Refusal to File ("RTF") letter from FDA on Friday May 20th at 2:48 pm EST, with regard to the Company's New Drug Application ("NDA") for Fexapotide Triflutate. Nymox's position... |